Associated Papers
TCR-engineered T cells targeting a shared β-catenin mutation eradicate solid tumors.
Eggebø MS et al.
Nature Immunology, 2025
40866620 (PubMed )
Supplement: 41590_2025_2252_MOESM11_ESM.xlsx › ED_Fig._4a
Select a paper to view details